AEMD
Income statement / Annual
Last year (2026), Aethlon Medical Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2026, Aethlon Medical Inc's net income was -$7.15 M.
See Aethlon Medical Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
03/31/2026 |
03/31/2025 |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$574.25 K |
$294.17 K |
$659.10 K |
$650.19 K |
$229.63 K |
$149.63 K |
$392.07 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.08 B
|
$2.63 B
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$574.25 K
|
$294.17 K
|
$659.10 K
|
$650.19 K
|
-$2.85 B
|
-$2.49 B
|
-$3.09 B
|
| Gross Profit Ratio |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
-12426.74
|
-16610.27
|
-7874.23
|
| Research and Development Expenses |
$0.00
|
$2.21 M
|
$2.52 M
|
$2.75 M
|
$2.34 M
|
$2.07 M
|
$927.00 K
|
$896.00 K
|
$586.00 K
|
$673.00 K
|
| General & Administrative Expenses |
$2.70 M
|
$5.05 M
|
$7.01 M
|
$7.51 M
|
$5.69 M
|
$4.90 M
|
$4.10 M
|
$2.98 M
|
$2.21 M
|
$2.86 M
|
| Selling & Marketing Expenses |
$0.00
|
$4.30 M
|
$5.63 M
|
$4.96 M
|
$5.03 M
|
$3.65 M
|
$2.48 M
|
$3.25 M
|
$2.77 M
|
$3.63 M
|
| Selling, General & Administrative Expenses |
$2.70 M
|
$9.34 M
|
$12.64 M
|
$12.47 M
|
$10.72 M
|
$8.55 M
|
$6.58 M
|
$6.23 M
|
$4.98 M
|
$6.49 M
|
| Other Expenses |
$4.60 M
|
-$2.21 M
|
-$2.52 M
|
-$2.75 M
|
-$2.34 M
|
-$2.07 M
|
-$927.00 K
|
-$896.00 K
|
-$586.00 K
|
-$673.43 K
|
| Operating Expenses |
$7.29 M
|
$9.34 M
|
$12.64 M
|
$12.47 M
|
$10.72 M
|
$8.55 M
|
$6.58 M
|
$6.23 M
|
$4.98 M
|
$6.49 M
|
| Cost And Expenses |
$7.29 M
|
$9.34 M
|
$12.64 M
|
$12.47 M
|
$10.72 M
|
$8.55 M
|
$6.58 M
|
$6.23 M
|
$4.98 M
|
$6.49 M
|
| Interest Income |
$156.53 K
|
$298.12 K
|
$428.39 K
|
$10.97 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$14.37 K
|
$10.11 K
|
$0.00
|
$0.00
|
$0.00
|
$1.58 K
|
$54.23 K
|
$220.49 K
|
$361.60 K
|
$304.33 K
|
| Depreciation & Amortization |
$323.65 K
|
$339.56 K
|
$359.06 K
|
$240.89 K
|
$123.69 K
|
$39.94 K
|
$26.37 K
|
$30.70 K
|
$35.66 K
|
$32.41 K
|
| EBITDA |
-$6.81 M |
-$13.04 M |
-$11.85 M |
-$11.79 M |
-$10.30 M |
-$7.85 M |
-$5.90 M |
-$5.97 M |
-$5.30 M |
-$6.97 M |
| EBITDA Ratio |
0
|
0
|
0
|
-20.53
|
-35
|
-11.91
|
-9.08
|
-25.99
|
-35.44
|
-17.78
|
| Operating Income Ratio |
0
|
0
|
0
|
-20.72
|
-35.43
|
-11.97
|
-9.12
|
-26.13
|
-32.29
|
-15.55
|
| Total Other Income/Expenses Net |
$142.16 K
|
-$4.05 M
|
$428.39 K
|
-$131.15 K
|
$0.00
|
$0.00
|
-$450.05 K
|
-$220.00 K
|
-$869.00 K
|
-$1.21 M
|
| Income Before Tax |
-$7.15 M
|
-$13.39 M
|
-$12.21 M
|
-$12.03 M
|
-$10.42 M
|
-$7.89 M
|
-$6.38 M
|
-$6.22 M
|
-$5.70 M
|
-$7.31 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
-20.95
|
-35.43
|
-11.97
|
-9.81
|
-27.09
|
-38.1
|
-18.64
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$24.79 K
|
$0.00
|
$0.00
|
| Net Income |
-$7.15 M
|
-$13.39 M
|
-$12.21 M
|
-$12.03 M
|
-$10.42 M
|
-$7.89 M
|
-$6.37 M
|
-$6.20 M
|
-$5.68 M
|
-$7.28 M
|
| Net Income Ratio |
0
|
0
|
0
|
-20.95
|
-35.41
|
-11.97
|
-9.8
|
-26.98
|
-37.96
|
-18.56
|
| EPS |
-10.61 |
-85.8 |
-48.6 |
-58.6 |
-70.6 |
-65.2 |
-186.7 |
-513 |
-691.7 |
-1405.7 |
| EPS Diluted |
-10.61 |
-85.8 |
-48.6 |
-58.6 |
-70.6 |
-65.2 |
-186.7 |
-512.7 |
-691.7 |
-1410 |
| Weighted Average Shares Out |
$673.95 K
|
$156.08 K
|
$251.30 K
|
$205.40 K
|
$147.60 K
|
$120.90 K
|
$34.15 K
|
$12.08 K
|
$8.21 K
|
$5.18 K
|
| Weighted Average Shares Out Diluted |
$673.95 K
|
$156.08 K
|
$251.30 K
|
$205.40 K
|
$147.60 K
|
$120.90 K
|
$34.15 K
|
$12.08 K
|
$8.21 K
|
$5.18 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
